We examined nonviral, lipid-mediated gene transfer methods as potential tools for efficient transfection of articular chondrocytes. Transfection conditions were determined for primary cultures of normal human articular, osteoarthritic human articular and normal bovine articular chondrocytes using a lacZ reporter gene construct with the commercially available cationic liposomes Cellfectin, DMRIE-C, LipofectAmine, Lipofectin, LipoTaxi, TransFast and the lipid-based reagent FuGENE 6. Optimized conditions were then evaluated in an ex vivo model of chondrocyte transplantation. FuGENE 6 transfection produced the maximum levels of transgene expression. Transfection efficiency was cell type specific and affected by DNA concentration, lipid/DNA ratio and the presence of hyaluronidase, a matrix-degrading
Introduction
Injured adult articular cartilage does not heal. 1 Current therapeutic options for repairing articular cartilage lesions include continuous passive motion of the joint, 2 periosteal 3 or osteochondral 4 grafts, subchondral plate perforation 5 and cell-based strategies. 6 This diversity attests to the unsolved status of articular cartilage repair. Therapeutic approaches to restore articular cartilage damage in degenerative joint disease are even more limited. 7 The ability to express recombinant genes in synovial cells lining the joint space has raised the prospect of treating joint diseases by gene therapy. [8] [9] [10] [11] Genetically engineered chondrocytes could be similarly used to enhance cartilage repair or to modulate the progression of cartilage degeneration. 12 However, direct introduction of genes into cartilage has been difficult to achieve, in part due to the extracellular matrix in which the articular chondrocytes are embedded. 13 Recent studies have shown that isolated articular chondrocytes can be transduced with viral vectors ex vivo and transplanted on to cartilage. [14] [15] [16] [17] Nonviral gene delivery systems 18 are an alternative that avoids the risk of insertional mutagenesis of retroviruses, the risk of immunogenicity of adenoviruses and the risk of acquiring replication competence.
enzyme. Analysis of X-gal staining demonstrated an efficiency of 41.0% in normal bovine articular chondrocytes, 20.7% in normal human articular chondrocytes and 7.8% in osteoarthritic human chondrocytes. Transfected chondrocytes were found to successfully populate the articular cartilage surface in explant cultures. Transplanted genetically modified chondrocytes adhered to the articular cartilage and continued to produce ␤-galactosidase for 2 weeks. This evaluation and optimization of lipid-based gene transfer into articular chondrocytes may serve as a useful tool in studies of genes involved in articular cartilage damage and repair and as a potential delivery method for therapeutic genes. Gene Therapy (2000) 7, 286-291. 19 and other lipid-based systems have the additional advantages that they are easy and safe to prepare and do not restrict the size of the DNA that can be delivered. 20, 21 The total amount of DNA used and the lipid reagent/DNA ratio influence the transfection efficiency of these systems and optimal transfection conditions vary among different cell types for each individual method. 22 Under carefully optimized conditions, these methods yield high efficiencies in several cell types in vitro and in vivo and have been used in human gene therapy protocols. 20, 23 While transfection of avian embryonic [24] [25] [26] or juvenile mammalian 27, 28 chondrocytes has been reported, successful nonviral transfection of adult articular chondrocytes has not been forthcoming. In particular the applicability and effectiveness of lipid-based methods in adult human articular chondrocytes and the effect of cartilage disease have not, to our knowledge, been evaluated.
Cationic liposomes
In this study we tested the hypothesis that lipid-based transfection systems are capable of efficiently transfecting primary cultures of articular chondrocytes. Using the Escherichia coli (E. coli) ␤-galactosidase (lacZ) gene, we determined optimal DNA amount and lipid reagent/DNA ratios for each tested lipid formulation in primary cultures of normal human articular, osteoarthritic human articular and normal bovine articular chondrocytes. In addition, we evaluated supplemental treatments to increase transfection efficiency further. Finally, we attempted to populate bovine articular cartilage organ cultures with transfected chondrocytes expressing lacZ.
Results

Transfection of bovine articular chondrocytes
For all lipid formulations tested, transfection efficiency varied with both the lipid/DNA ratio and the total DNA content used for transfection. Of the eight transfection systems tested, FuGENE 6 produced the highest transfection efficiency (Figure 1 ). The effect of DNA content on transfection efficiency was biphasic. Increasing the DNA content to 1 g DNA produced a dose-dependent increase in efficiency. Greater quantities of DNA reduced the transfection efficiency (Table 1) . Maximal gene expression was seen at a (v/w) FuGENE 6/DNA ratio of 3:1. The maximal efficiencies for all other tested lipid preparations were also dependent on lipid/DNA ratio and total amount of DNA used, but were less than 26% of the maximal efficiency of FuGENE 6 (P Ͻ 0.001). To determine whether the efficiency of FuGENE 6 could be further increased, chondrocytes were treated with hyaluronidase before and during transfection with FuGENE 6. Hyaluronidase increased FuGENE 6 transfection efficiency from 6.9% to 41.0% (P Ͻ 0.0001) when delivered both before and during transfection ( Figure 2 ).
Transfection of normal human articular chondrocytes
Among all tested transfection systems, transfection efficiency of normal human articular chondrocytes was highest with FuGENE 6 (Figure 1 ). The maximal FuGENE 6 transfection efficiency of 9.0% was obtained with 1 g DNA and a (v/w) FuGENE 6/DNA ratio of 3:1 ( Table 1) . The maximal efficiencies of other lipid preparations were significantly lower, ranging from 1.8% (LipoTaxi; P Ͻ 0.0001) to 0.1% (Cellfectin; P Ͻ 0.0001). Treatment of normal human articular chondrocytes with 4 U/ml hyaluronidase for 12 h before and during transfection with FuGENE 6 increased transfection efficiency from 9.0 ± 0.9% to 20.7 ± 0.7% (P Ͻ 0.0001). Hyaluronidase increased transfection efficiencies of DMRIE-C 2.7-fold (P = 0.02). In addition to hyaluronidase, several other measures to increase efficiency were examined. No further increase in efficiency (8.5 ± 0.4%, P Ͼ 0.05) occurred when hyaluronidase was supplemented with polybrene, a polycation that is thought to facilitate the interaction of the lipid/DNA complexes with the cell membrane. 29 Transfection of osteoarthritic human articular chondrocytes In osteoarthritic human articular chondrocytes, the highest transfection efficiency observed with lipid-based transfection reagents alone was 3.9% ( Figure 1 ). This was achieved with FuGENE 6 with 1 g DNA and a (v/w) lipid/DNA ratio of 2:1 ( Table 1) . As with normal human and bovine articular chondrocytes, hyaluronidase further increased FuGENE 6 transfection efficiency. The maximal efficiency of 7.8% was achieved when hyaluronidase was added at a concentration of 4 U/ml for 12 h before and during transfection, yielding a 2.0-fold increase compared with the non-treated control (P Ͻ 0.01). The effect on FuGENE 6 transfection efficiency of polybrene with or without hyaluronidase was variable and no dosedependent effect of polybrene with or without hyaluronidase was observed (data not shown).
Transplantation of transfected bovine articular chondrocytes Transfection of bovine articular chondrocytes was performed with FuGENE 6 using the optimized conditions of a 3:1 (v/w) lipid/DNA ratio and 4 U/ml hyaluronidase. Transfected cells, transplanted on to articular cartilage disks in organ culture, were defined by X-gal staining. Examination of cultured cartilage disks by stereoscopy revealed a pattern of multiple foci of X-gal staining, distributed over the seeded cartilage surface (Figure 3a) . In transplanted control cultures exposed to FuGENE 6 without the lacZ expression vector, no X-gal positive cells were observed. When chondrocytes were seeded at one-half the cell density (0.5 × 10 5 cells per disk), the surface demonstrated a similar, but less intense staining. On histological analysis of transverse sections of the organ cultures, the transplanted cells formed a layer of X-gal positive and X-gal negative cells attached to the surface of the articular cartilage (Figure 3b ). Safranin O staining revealed that the transplanted chondrocytes were embedded in a proteoglycan-containing matrix. Studies of the time course of lacZ expression demonstrated a peak 8 days after transfection, followed by a decrease in expression on day 14. There was no detectable activity based on X-gal staining 21 days after transfection (data not shown). 
Discussion
The effectiveness of nonviral, lipid-based technologies for transfection of mammalian articular chondrocytes has not been systematically evaluated to date. The results of the present study demonstrate the feasibility of efficient nonviral gene transfer in primary cultures of articular chondrocytes, including neonatal bovine and normal adult human cells. The data further suggest that efficiency of transfection is reduced in chondrocytes derived from osteoarthritic human cartilage. In addition, we have demonstrated that the optimized transfection conditions may be used to genetically modify chondrocytes that are cap-able of populating the surface of bovine articular cartilage in organ culture.
The FuGENE 6 lipid preparation was the most effective of the lipid-based systems tested, yielding transfection efficiencies of 7.6% for bovine articular chondrocytes, 9.0% for normal human articular and 3.7% for osteoarthritic human articular chondrocytes. In the presence of supplemental treatments, the efficiency was further increased to 41.0% for bovine articular chondrocytes, 20.7% for normal human articular and 7.8% for osteoarthritic human articular chondrocytes. These efficiencies are adequate for transfection-based molecular analyses. Although maximal transfection efficiency in osteoarthritic chondrocytes was comparatively low, it may be sufficient to elicit a biological response and be of potential therapeutic efficacy. As studies in the arterial wall have shown, transfection of only 0.1-1% of cells with a fibroblast growth factor-1 or a platelet-derived growth factor B expression vector was capable of achieving a biological effect in vivo. 30, 31 Optimizing the molar charge ratio of lipid to DNA and the total amount of DNA critically influences transfection efficiency. 22 For optimal interaction with negatively charged cell membranes, the net charge of the lipid-DNA complex has to be positive. 32 For the nonliposomal lipid formulation FuGENE 6, the most effective transfection system of this study, the optimal (v/w) lipid/DNA ratio was 3:1 for bovine and normal human articular chondrocytes and was 2:1 for osteoarthritic human chondrocytes.
Previous studies have established that liposomal gene transfer efficiency may vary up to 100-fold, depending on the cell type. 19 To date, most experience with lipidmediated transfection of chondrocytes has been with chicken embryonic chondrocytes 25, 26 and primary rabbit 28 articular chondrocytes. For example, prior studies testing different promoters used the cationic liposomes Lipofectin 25 or LipofectAmine 26 to transfect hypertrophic and nonhypertrophic chicken embryonic chondrocytes. The suitability of these techniques to adult human chondrocytes has been uncertain, since these cells have been refractory to transfection. 27 We found that the liposome types that were effective for embryonic avian chondrocytes were less useful in neonatal and adult mammalian chondrocytes. The data suggest that optimal transfection methods are specific for chondrocytes derived from different species or ages.
A potential mechanism for the higher efficiencies obtained in neonatal bovine articular chondrocytes than in adult human articular chondrocytes is a difference in cell proliferation rate. Studies in other cell types have demonstrated that optimal lipofection requires mitotic activity. 33, 34 A variety of other factors, including differences in cell-specific endosomal and lysosomal activity, nuclear transport and nuclear stability of exogenous DNA may also contribute to these observed differences. 35 Transfection efficiency may also be influenced by duration of exposure and it is possible that further optimization may be achievable by modulating lipid/DNA exposure time to the cells.
To improve transfection efficiency in these cells further, we evaluated the effects of several potential facilitators of chondrocyte transfection. Hyaluronidase has been used to increase transfection efficiency of chick embryo chondrocytes with Lipofectin 25 or DOTAP 24 (N-[1-(2,3-Dioloyloxy ) propyl ] -N,N,N-trimethylammoniummethylGene Therapy sulfate) and of human juvenile costal chondrocytes 27 or 1-2-month-old rabbit articular chondrocytes 28 with calcium phosphate co-precipitates. This enzyme is thought to improve lipid/DNA complex access to the cellular membrane by partially degrading the pericellular matrix. In the present study, hyaluronidase significantly enhanced transfection efficiency in all three chondrocyte types studied. A 24-h exposure of bovine articular chondrocytes to hyaluronidase increased efficiency 5.9-fold, but it increased efficiency only two-fold in osteoarthritic human chondrocytes. These results may reflect differences in the pericellular matrix. We also investigated the effect of polybrene on transfection efficiency. 29 In human articular chondrocytes, polybrene abolished the beneficial effect of hyaluronidase treatment. Treatment of osteoarthritic human chondrocytes with polybrene alone or in combination with hyaluronidase had no consistent effect.
One potential application of articular chondrocyte transfection is the repopulation of articular cartilage with chondrocytes expressing a therapeutic gene. Such an application would require that transfected chondrocytes be able to attach to articular cartilage and continue to express the transgene for a biologically appropriate period of time. Our results showed that these transfected chondrocytes adhere to the articular surface, produce extracellular matrix and continue to express the product of the transgene at least 2 weeks after transplantation. This time frame is comparable to that of adenoviral transduction of osteoarthritic human chondrocytes, in which lacZ expression was detectable for 8 days 14 and for 27 days 17 in organ culture. Taken together, our results indicate that lipid-based methods may be optimized sufficiently to offer a feasible approach for gene transfer into articular chondrocytes, including adult human articular chondrocytes. The data further demonstrate that this method may be applicable to gene transfer as an adjunct to chondrocyte transplantation. Additional studies will be required to determine the optimal in vivo conditions with which to pursue this approach further. 
Materials and methods
Materials
Cell culture
Normal human articular cartilage was obtained from knee or hip joints removed during tumor surgery. Osteoarthritic human articular cartilage was obtained from joints treated by total knee arthroplasty. Bovine articular cartilage was obtained from radiocarpal joints of 1 to 2-week-old calves. 36 For human cartilage, the calcified zone was excluded. For bovine cartilage, underlying vascularized cartilage was excluded. Harvested cartilage was washed, diced into 2 × 2 mm pieces and transferred to DMEM with 100 U/ml penicillin G and 100 l/ml streptomycin (basal medium) containing collagenase at 37°C in a humidified atmosphere with 5% CO 2 for 16 h. Isolated cells were filtered through a 125 m mesh to remove undigested matrix. Bovine chondrocytes were isolated with 0.08-0.09% collagenase and human chondrocytes with 0.2% collagenase. Cell number was determined by hemocytometry. Viability, as determined by trypan blue exclusion, always exceeded 90%. Isolated chondrocytes were placed in monolayer culture in 24-well plates at a density of 6 × 10 4 cells per well in basal medium containing 10% fetal bovine serum (growth medium). Transfection experiments were performed with primary cell cultures 1-2 days after seeding at 60-70% cell density.
Plasmid DNA and transfection procedures
The eukaryotic expression vector pCMVSport␤ containing the E. coli lacZ gene under the control of the cytomegalovirus immediate-early promoter and enhancer was propagated in DH5␣ competent cells. Ultrapure endotoxin-free plasmid DNA was prepared using the Qiagen Endofree Plasmid Maxi Kit according to the manufacturer's instructions. 37 The chondrocyte monolayer was rinsed once with Opti-MEM or DMEM (FuGENE 6, Effectene). For transfections, liposome/DNA or non-liposomal lipid/DNA complexes were prepared according to the manufacturer's instructions in sterile polypropylene tubes and added to the chondrocytes. Cells were incubated at 37°C for 4 h (FuGENE 6, TransFast), 6 h (LipoTaxi) or 9-10 h (DMRIE-C, LipofectAmine, Lipofectin, Cellfectin), washed with DMEM and incubated for a further 48 h with growth medium. To optimize the contribution of DNA dose and transfection reagent (lipid)/DNA ratio to transfection efficiency, total amounts of DNA were varied between 0.2 g and 1.5 g DNA and lipid/DNA ratios were varied between (v/w) 2:1 and 14:1. Bovine testicular hyaluronidase (0, 4 or 40 U/ml) or polybrene (0, 5, 8 or 15 g/ml) were added at the denoted time-points.
Cartilage organ culture and cell transplantation Articular cartilage organ cultures were prepared from the radiocarpal joints of 1-to 2-week-old calves as cartilage disks (7 mm diameter) and individually incubated in sixwell plates containing basal medium with 2% fetal bovine serum. Two to 5 days later, transplantation of isolated, transfected chondrocytes was performed by a modification of previously described techniques. 38 Briefly, isolated bovine articular chondrocytes were transfected with FuGENE 6, incubated for 24 h, trypsinized, washed and suspended in growth medium at 5 × 10 3 cells/l. Chondrocytes were seeded on to the surface of 6-mm diameter disks at a density of 1 × 10 5 cells per disk. Since initial experiments revealed that the layer of transplanted cells is only loosely connected to the cartilage surface, cartilage disks were pretreated with 2.5% trypsin for 1 h before transplantation at 37°C and washed twice with phosphate-buffered saline (PBS) before seeding to improve attachment. 39 Cultures were maintained up to 21 days and examined at days 2, 8, 14 and 21 after transfection.
X-gal staining and histological analysis Transfection efficiency was determined at a standardized representative time-point of 48 h by X-gal staining and histological analysis. Transfected chondrocytes were fixed and stained for 6 h at 37°C for ␤-galactosidase (Insitu ␤-galactosidase Staining Kit, Stratagene). The number of X-gal positive cells was determined by counting stained cells in sequential microscope fields (0.77 mm 2 each) along the horizontal and vertical diameters of the well of a 24-well plate. When transfection efficiencies were particularly low (eg Ͻ1.0%), all stained cells per well were counted. The total cell number per well was determined by counting all (stained and unstained) cells in 10-20 of these defined microscope fields in three to four representative wells of the 24-well plate and by expressing them as cells per well. Transfection efficiency was defined as the ratio of positive to total cells. Organ cultures of cartilage with transplanted, transfected chondrocytes were fixed in 10% formalin and embedded in paraffin. Serial sections (5 m) were stained with safranin O and examined by light microscopy for distribution of ␤-galactosidase-positive cells.
Statistical analysis
Data are expressed as mean ± standard deviation (s.d.) of separate experiments. Within each experiment, each test condition was performed in quadruplicate. Optimization of bovine articular chondrocyte transfection was performed in two to four repeated experiments, depending on the method tested. Optimization of normal human articular chondrocyte transfection was performed in five repeated experiments and that of osteoarthritic human chondrocytes in eight repeated experiments. The Student's t test was used to determine the significance of differences between groups. P values less than 0.05 were considered significant.
